Overview

• Health Subsecretary Eduardo Clark listed at least 33 companies that have not fulfilled contracts, including Bioxintegral Servicios with 100% undelivered, Productos Farmacéuticos with 88.6%, Serral with 83.7%, and Puerta del Sol Capital with 14.1 million pieces pending.
• Government data show availability near full coverage—IMSS at 97%, ISSSTE at similar levels, IMSS‑Bienestar at 92%, and oncologics at 96%—with shortfalls attributed to supplier breaches.
• The administration is authorizing replacement purchases at contracted prices and set a deadline through September for compliance, with debarment and possible criminal complaints in cases of malicious conduct.
• IMSS‑Bienestar began the second stage of Rutas de la Salud on September 22 to supply 8,342 centers with 9,632 preassembled kits of 147 essential drugs via more than 1,100 routes, after a first phase that delivered 28 million pieces to 8,061 centers and 578 hospitals.
• Oncology medicines now move directly from the megafarmacia to 56 IMSS‑Bienestar cancer centers to avoid state warehouses, and public portals let users track deliveries and procurement in real time.